Updated Feb. 7, 2014 at 4:24 p.m.

Premium Lock Argos IPO raises $45M for cancer immunotherapy trials

Published: 2014-02-07 11:56:00
Updated: 2014-02-07 16:24:40

Argos' immunotherapy process Argos' immunotherapy process as explained in an animation at its website. Image 1 of 2 · Next Image…

Argos Therapeutics slashed its IPO price to $8 per share after initially planning go public at between $13 ad $15 per share. Read how Argos plans to spend its IPO proceeds....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll